ALSO: Iambic files for a Nasdaq IPO into a rebounding market; Up to $1.4B for desining oral macrocycles with AI; Stanford researchers turn manuscripts into AI agents that collaborate, and more...
Interesting insights, Andrii. From a technology builder’s perspective, I believe the next challenge is moving beyond impressive AI demonstrations to dependable, measurable outcomes in everyday scientific workflows. That is where domain-specific AI, trusted evidence, and human expertise need to come together.
Interesting insights, Andrii. From a technology builder’s perspective, I believe the next challenge is moving beyond impressive AI demonstrations to dependable, measurable outcomes in everyday scientific workflows. That is where domain-specific AI, trusted evidence, and human expertise need to come together.
Exactly!